QYR Market Research Global Human Rabies Immunoglobulin (IM) market | Page 5

QYResearch
Human Rabies Immunoglobulin (IM) is widely used for
the Category II Exposure and Category III Exposure,
the most proportion of Human Rabies Immunoglobulin
(IM) is used for Category III Exposure, and the
proportion in 2017 is about 82.6%.
China is the largest sales place, with a sales market
share nearly 61.4% in 2017, because of the population.
North America enjoys 4.3% market share.
www.qyresearch.com
www.qyresearch.com